In a one pot procedure, 18 compounds of 7-(substituted phenyl)-2-substituted-6,7-dihydro-4H-[1,2,4]triazolo[1,5-a] pyrimidin-5-one derivatives (16-33) have been synthesized. 3(5)-Amino-5(3)-substituted-1,2,4-triazole derivatives (7-12) were used as synthomes which were cyclo-condensed by fusion with substituted methyl cinnamate esters (13-15) to afford the target compounds (16-33). In an effort to develop new non-nucleoside antiviral agents, compounds 16-33 were evaluated for their anti-HIV-1 and anti-HSV-1 activities. Complete inhibition of the proliferation of HIV-1 viruses was achieved by compounds 22, 23 and 24 at concentrations of 25, 25 and 50 micrograms/ml, respectively. 7-Phenyl-2-(n-pentyl)-6,7-dihydro-4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one (19) exhibited potential activity against HSV-1 with 88% reduction in the viral plaques. The suggested marked specificity of this class of compounds as anti-HIV-1 and HSV-1 agents is discussed.
Fused pyrimidine derivativesFused pyrimidine derivatives R 0515 Synthesis and Evaluation of anti-HIV-1 and anti-HSV-1 Activities of 4H-[1,2,4]-Triazolo[1,5-a]pyrimidin-5-one Derivatives. -With the aim to develop new non-nucleoside antiviral agents, title compounds (V) (18 examples) are prepared via fusion of aminotriazoles (III) with cinnamate esters (IV) and evaluated for their anti-HIV-1 and anti-HSV-1 activities. Complete inhibition of the proliferation of HIV-1 viruses can be achieved by compounds (Vb)-(Vd) bearing a cyclohexyl group at C-2. Moreover, compound (Va) exhibits potential activity against HSV-1. -(ABDEL-HAFEZ*, A. A.; ELSHERIEF, H. A. H.; JO, M.; KUROKAWA, M.; SHIRAKI, K.; KAWAHATA, T.; OTAKE, T.; NAKAMURA, N.; HATTORI, M.; Arzneim.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.